Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Inghirami

Showing results (151-160 of 239) with videos related to

Pageof 24
Sort By:
British Journal of Haematology|August 16, 2023
ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cellsElaine Y L Chung, Giulio Sartori, Maurilio Ponzoni, et al.
Cancer Discovery|February 5, 2021
Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental SignaturesNikita Kotlov, Alexander Bagaev, Maria V Revuelta, et al.
Cancer Research|September 5, 2006
p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signalingJames Hulit, Richard J Lee, Zhiping Li, et al.
Developmental Cell|May 30, 2024
Epithelial aPKC deficiency leads to stem cell loss preceding metaplasia in colorectal cancer initiationHiroto Kinoshita, Anxo Martinez-Ordoñez, Tania Cid-Diaz, et al.
British Journal of Haematology|April 21, 2018
Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implicationsSabina Chiaretti, Monica Messina, Sara Grammatico, et al.
Haematologica|May 9, 2024
Targeting CD19-positive lymphomas with the antibodydrug conjugate loncastuximab tesirine: preclinical evidence of activity as a single agent and in combination therapyChiara Tarantelli, David Wald, Nicolas Munz, et al.
Nature Cell Biology|March 8, 2019
Author Correction: The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signallingTomoyo Okada, Surajit Sinha, Ilaria Esposito, et al.
Nature Cell Biology|December 23, 2014
The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signallingTomoyo Okada, Surajit Sinha, Ilaria Esposito, et al.
Blood|July 22, 2021
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell ProjectRanjana H Advani, Tetiana Skrypets, Monica Civallero, et al.
Blood Advances|September 22, 2021
Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasmOriana Miltiadous, Kseniya Petrova-Drus, Shipra Kaicker, et al.
Pageof 24

Showing results (151-160 of 239) with videos related to

Sort By:
Pageof 24
British Journal of Haematology|August 16, 2023
ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cellsElaine Y L Chung, Giulio Sartori, Maurilio Ponzoni, et al.
Cancer Discovery|February 5, 2021
Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental SignaturesNikita Kotlov, Alexander Bagaev, Maria V Revuelta, et al.
Cancer Research|September 5, 2006
p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signalingJames Hulit, Richard J Lee, Zhiping Li, et al.
Developmental Cell|May 30, 2024
Epithelial aPKC deficiency leads to stem cell loss preceding metaplasia in colorectal cancer initiationHiroto Kinoshita, Anxo Martinez-Ordoñez, Tania Cid-Diaz, et al.
British Journal of Haematology|April 21, 2018
Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implicationsSabina Chiaretti, Monica Messina, Sara Grammatico, et al.
Haematologica|May 9, 2024
Targeting CD19-positive lymphomas with the antibodydrug conjugate loncastuximab tesirine: preclinical evidence of activity as a single agent and in combination therapyChiara Tarantelli, David Wald, Nicolas Munz, et al.
Nature Cell Biology|March 8, 2019
Author Correction: The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signallingTomoyo Okada, Surajit Sinha, Ilaria Esposito, et al.
Nature Cell Biology|December 23, 2014
The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signallingTomoyo Okada, Surajit Sinha, Ilaria Esposito, et al.
Blood|July 22, 2021
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell ProjectRanjana H Advani, Tetiana Skrypets, Monica Civallero, et al.
Blood Advances|September 22, 2021
Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasmOriana Miltiadous, Kseniya Petrova-Drus, Shipra Kaicker, et al.
Pageof 24